A clear identification of the primary site of tumor is of great importance to the next targeted site-specific treatments and could efficiently improve patients overall survival. Even though many classifiers based on gene expression had been proposed to predict the tumor primary, only a few studies focus on using DNA methylation (DNAm) profiles to develop classifiers, and none of them compares the performance of classifiers based on different profiles.